Lista de obras - Roman Prymula - Dominio Público Uruguay

10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.

artículo científico publicado en 2009

A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I).

artículo científico publicado en 2014

A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II).

artículo científico publicado en 2014

A repeated syphilis infection imported from Thailand in an HIV positive couple of men-who-have-sex-with-men in Czech Republic

artículo científico publicado en 2013

Acceptance and opinions of Intanza/IDflu intradermal influenza vaccine in the Czech Republic and Turkey

artículo científico publicado en 2012

Adult vaccination in 11 Central European countries - calendars are not just for children

artículo científico publicado en 2012

Alternatives to HIST for acellular pertussis vaccines: progress and challenges in replacement

artículo científico publicado en 2016

Anthrax vaccines

artículo científico publicado en 2005

Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.

artículo científico publicado en 2012

Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination

artículo científico publicado en 2010

Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children

artículo científico publicado en 2010

Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for the introduction of HPV vaccines

artículo científico publicado en 2009

Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine

artículo científico publicado en 2019

Clinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and Slovakia

artículo científico publicado en 2013

Clinical experience with DTPw-HBV and DTPw-HBV/Hib combination vaccines

artículo científico publicado en 2008

Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013.

artículo científico publicado en 2016

Comparison of Streptococcus pneumoniae serotypes causing acute otitis media & invasive disease in young children in the Czech Republic

artículo científico publicado en 2004

Comparison of immunogenicity and safety between two paediatric TBE vaccines.

artículo científico publicado en 2010

Concomitant vaccination against hepatitis A and typhoid fever

artículo científico publicado en 1998

Corrigendum to “Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial” [Vacci

scientific article published on 05 May 2017

ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis media

scientific article published on 26 December 2006

Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.

artículo científico publicado en 2009

Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age.

artículo científico publicado en 2009

Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants

artículo científico publicado en 2012

Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study

scientific article published on 01 November 2007

Epidemiological characteristics of pertussis in Estonia, Lithuania, Romania, the Czech Republic, Poland and Turkey-1945 to 2005.

artículo científico publicado en 2008

Evaluation of reactogenicity and immunogenicity of two influenza vaccines (vaxigrip and fluarix) in the season 1996-1997.

artículo científico publicado en 1998

Hepatitis A - Do we still need new vaccines?

artículo científico publicado en 2009

Hepatitis A vaccination by Havrix in the Czech U.N. Troops according to data of seroprevalence in 1991-1995.

artículo científico publicado en 1996

How can we improve compliance with vaccination in Europe?

artículo científico publicado en 2015

Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations

artículo científico publicado en 2014

Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech Republic

scientific article published on 01 August 2018

Immunogenicity and safety of a booster dose of the 13-valent pneumococcal conjugate vaccine in children primed with the 10-valent or 13-valent pneumococcal conjugate vaccine in the Czech Republic and Slovakia

artículo científico publicado en 2017

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

artículo científico publicado en 2013

Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe

artículo científico publicado en 2010

Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.

artículo científico

Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors

artículo científico publicado en 2007

Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic para

artículo científico publicado en 2013

Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage

artículo científico publicado en 2011

Influenza vaccination in the elderly.

artículo científico publicado en 2017

Kinetics of the immune response following pneumococcal PD conjugate vaccination

scientific article published on 26 December 2006

Medialization thyroplasty with a customized silicone implant: clinical experience

artículo científico publicado en 2008

Meningococcal serogroup B vaccine (4CMenB): Booster dose in previously vaccinated infants and primary vaccination in toddlers and two-year-old children

artículo científico publicado en 2015

Online survey: knowledge about risks, prevention and consequences of infections with HBV among travellers from four European countries.

artículo científico publicado en 2011

Opportunity for healthy ageing: lessening the burden of adult pneumococcal disease in Central and Eastern Europe, and Israel.

artículo científico publicado en 2012

Paediatric pneumococcal disease in Central Europe

artículo científico publicado en 2011

Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of Age.

artículo científico publicado en 2016

Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial

artículo científico publicado en 2016

Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules

artículo científico publicado en 2017

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

artículo científico publicado en 2006

Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics.

artículo científico publicado en 2009

Prevention of otitis media: now a reality?

artículo científico publicado en 2009

Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons

artículo científico publicado en 2018

Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial

artículo científico

Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial

artículo científico publicado en 2020

Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery.

artículo científico publicado en 2018

Rational design of novel TLR4 ligands by in silico screening and their functional and structural characterization in vitro.

artículo científico publicado en 2018

Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines

artículo científico publicado en 2009

Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG).

artículo científico publicado en 2013

Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid)

artículo científico publicado en 2016

Regional advisory board position statement on optimal pneumococcal vaccination in adults. Update to 2011 consensus on adult pneumococcal disease: update on optimal pneumococcal vaccination in adults

artículo científico publicado en 2013

Rotavirus vaccination in central Europe.

artículo científico publicado en 2013

Rubella revisited: where are we on the road to disease elimination in Central Europe?

artículo científico publicado en 2011

Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine: A Randomized, Controlled Trial in Adolescent Girls

article by Doris M. Rivera Medina et al published May 2010 in Journal of Adolescent Health

Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial.

artículo científico publicado en 2014

Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B,

artículo científico publicado en 2008

Safety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: Results from a randomized phase II study in infants

artículo científico publicado en 2017

Structural Properties of Potential Synthetic Vaccine Adjuvants - TLR Agonists.

artículo científico

Szczepienia dorosłych w 11 krajach Europy Środkowej – kalendarze szczepień nie tylko dla wieku dziecięcego

The immunogenicity and reactogenicity of a new DTPw-HBV vaccine as a primary and booster vaccination course in healthy infants.

artículo científico publicado en 2007

The seroprevalence of the "total" anti-HAV antibody in the Czech UNPRO Forces (1991-1995).

artículo científico publicado en 1996

University partnership project in health services management education: the driving force behind the Czech Republic Educational Network

artículo científico publicado en 1997

Use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in a clinical trial in 3630 infants

Vaccination in newly arrived immigrants to the European Union

artículo científico publicado en 2017

Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward

article

Vakcinace proti MMVR ⬇️

Varicella vaccine without human serum albumin versus licensed varicella vaccine in children during the second year of life: a randomized, double-blind, non-inferiority trial

artículo científico publicado en 2016

[Analysis of prevention of an epidemic of viral hepatitis A in the Czech army 1970-1989]

artículo científico publicado en 1994

[Epidemiology of noninfectious diseases--principles and methodology]

artículo científico publicado en 1995

[Present view of conjugated pneumococcus vaccines]

artículo científico publicado en 2006

[Seroprevalence of anti-hepatitis A antibodies in Czech soldiers serving in U.N. forces--suggestions for a hepatitis A vaccination schedule]

scientific article published on 01 December 1995

[Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age]

scientific article published on 01 August 2006

Lista de obras de Roman Prymula

10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.

A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I).

A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in infants (II).

A repeated syphilis infection imported from Thailand in an HIV positive couple of men-who-have-sex-with-men in Czech Republic

Acceptance and opinions of Intanza/IDflu intradermal influenza vaccine in the Czech Republic and Turkey

Adult vaccination in 11 Central European countries - calendars are not just for children

Alternatives to HIST for acellular pertussis vaccines: progress and challenges in replacement

Anthrax vaccines

Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.

Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination

Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children

Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for the introduction of HPV vaccines

Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine

Clinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and Slovakia

Clinical experience with DTPw-HBV and DTPw-HBV/Hib combination vaccines

Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013.

Comparison of Streptococcus pneumoniae serotypes causing acute otitis media & invasive disease in young children in the Czech Republic

Comparison of immunogenicity and safety between two paediatric TBE vaccines.

Concomitant vaccination against hepatitis A and typhoid fever

Corrigendum to “Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial” [Vacci

ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis media

Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.

Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age.

Efficacy and immunogenicity of live-attenuated human rotavirus vaccine in breast-fed and formula-fed European infants

Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study

Epidemiological characteristics of pertussis in Estonia, Lithuania, Romania, the Czech Republic, Poland and Turkey-1945 to 2005.

Evaluation of reactogenicity and immunogenicity of two influenza vaccines (vaxigrip and fluarix) in the season 1996-1997.

Hepatitis A - Do we still need new vaccines?

Hepatitis A vaccination by Havrix in the Czech U.N. Troops according to data of seroprevalence in 1991-1995.

How can we improve compliance with vaccination in Europe?

Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations

Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech Republic

Immunogenicity and safety of a booster dose of the 13-valent pneumococcal conjugate vaccine in children primed with the 10-valent or 13-valent pneumococcal conjugate vaccine in the Czech Republic and Slovakia

Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials

Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe

Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.

Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors

Immunological memory and nasopharyngeal carriage in 4-year-old children previously primed and boosted with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) with or without concomitant prophylactic para

Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage

Influenza vaccination in the elderly.

Kinetics of the immune response following pneumococcal PD conjugate vaccination

Medialization thyroplasty with a customized silicone implant: clinical experience

Meningococcal serogroup B vaccine (4CMenB): Booster dose in previously vaccinated infants and primary vaccination in toddlers and two-year-old children

Online survey: knowledge about risks, prevention and consequences of infections with HBV among travellers from four European countries.

Opportunity for healthy ageing: lessening the burden of adult pneumococcal disease in Central and Eastern Europe, and Israel.

Paediatric pneumococcal disease in Central Europe

Persistence of Bactericidal Antibodies After Infant Serogroup B Meningococcal Immunization and Booster Dose Response at 12, 18 or 24 Months of Age.

Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial

Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics.

Prevention of otitis media: now a reality?

Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons

Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial

Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial

Rational Design of a New Class of Toll-Like Receptor 4 (TLR4) Tryptamine Related Agonists by Means of the Structure- and Ligand-Based Virtual Screening for Vaccine Adjuvant Discovery.

Rational design of novel TLR4 ligands by in silico screening and their functional and structural characterization in vitro.

Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines

Recommendations for tick-borne encephalitis vaccination from the Central European Vaccination Awareness Group (CEVAG).

Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid)

Regional advisory board position statement on optimal pneumococcal vaccination in adults. Update to 2011 consensus on adult pneumococcal disease: update on optimal pneumococcal vaccination in adults

Rotavirus vaccination in central Europe.

Rubella revisited: where are we on the road to disease elimination in Central Europe?

Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine: A Randomized, Controlled Trial in Adolescent Girls

Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial.

Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B,

Safety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: Results from a randomized phase II study in infants

Structural Properties of Potential Synthetic Vaccine Adjuvants - TLR Agonists.

Szczepienia dorosłych w 11 krajach Europy Środkowej – kalendarze szczepień nie tylko dla wieku dziecięcego

The immunogenicity and reactogenicity of a new DTPw-HBV vaccine as a primary and booster vaccination course in healthy infants.

The seroprevalence of the "total" anti-HAV antibody in the Czech UNPRO Forces (1991-1995).

University partnership project in health services management education: the driving force behind the Czech Republic Educational Network

Use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in a clinical trial in 3630 infants

Vaccination in newly arrived immigrants to the European Union

Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward

Vakcinace proti MMVR ⬇️

Varicella vaccine without human serum albumin versus licensed varicella vaccine in children during the second year of life: a randomized, double-blind, non-inferiority trial

[Analysis of prevention of an epidemic of viral hepatitis A in the Czech army 1970-1989]

[Epidemiology of noninfectious diseases--principles and methodology]